Global Polio Vaccines Market – Industry Analysis and Forecast (2020-2027) – by Vaccines type, End user and Region.

Global Polio Vaccines Market – Industry Analysis and Forecast (2020-2027) – by Vaccines type, End user and Region.

Market Scenario

Global Polio Vaccines Market was valued at US$ 1.3 Mn in 2019 and is expected to reach US$ 4.2 Mn by 2027 at a CAGR of 15.7 %. Global Polio Vaccines Market, by Vaccines type The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding the global polio vaccines market dynamics, structure by identifying and analysing the market segments and project the global market size. Further, the report also focuses on the competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence. The report also provides PEST analysis, PORTER’s analysis, and SWOT analysis to address questions of shareholders to prioritizing the efforts and investment in the near future to the emerging segment in the global polio vaccines market. Polio basically affects children under 5 years of age. Up to 72% of all the infections in children are without any symptoms and nearby 25-30% of infections in children causes’ nonspecific illness without clinical or laboratory evidence of central nervous system invasion. This has created a gesture for the organizations to focus on the vaccines options for making a prophylactic approach towards the prevention of the disorder, which in turn is anticipated to fuel the polio vaccines market in the upcoming years. Polio vaccines industry growth is anticipated to accelerate over the next five years, driven by a rising in investments for the development of different types of polio vaccine. The global polio vaccines market has witnessed significant progress over the past few years because of the increased effort to eradicate polio across the world. According to the Global Eradication Polio Initiative, more than 15Mn cases of polio have been prevented by the oral polio vaccine and eradication of polio has been achieved in most target countries. Oral Polio Vaccine (OPV) segment is leading the global polio Vaccines market. One trend affecting polio Vaccines market is the cessation of the oral polio vaccine. There is a growing need for cessation of OPV as the use of OPV can result in cases of polio owing to circulating VDPV and vaccine-associated paralytic polio as oral vaccines contain weakened polioviruses. Region-wise, the largest market share in the global polio vaccines market was held by the North Americas, followed by Europe and APAC. In addition, the North Americas are forecasted to continue their dominance over the next five years, while APAC will lose out a part of their market share to Europe region. The Sanofi Pasteur and Bilthoven Biologicals/ Serum Institute of India are the 2 companies which were awarded in 2014 by UNICEF for the supply of IPV in 1, 5 and 10 dose vials, and long term supply agreements were established done to 2018.

Scope of Global Polio Vaccines Market

Global Polio Vaccines Market, by Vaccines type

• Inactivated Polio Vaccine (IPV) • Oral Polio Vaccine (OPV)

Global Polio Vaccines Market, by End user

• Hospital • Clinics • Public Services • Others

Global Polio Vaccines Market, by Region

• North America • Europe • Asia Pacific • Middle East and Africa • South America

Key players operating in Global Polio Vaccines Market

• Sanofi • GSK • Bibcol • Serum Institute • Tiantan Biological • IMBCA • Panacea Biotec Ltd • Bio-Med • Halfkin Bio-Pharmaceuticals Global Embryo Incubator Market

Table of Contents

Global Polio Vaccines Market

1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Polio Vaccines Market Size, by Market Value (US$Mn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Polio Vaccines Market Analysis and Forecast 6.1. Global Polio Vaccines Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Polio Vaccines Market Analysis and Forecast, by End user 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Polio Vaccines Market Value Share Analysis, by End user 7.4. Global Polio Vaccines Market Size (US$Mn) Forecast, by End user 7.5. Global Polio Vaccines Market Analysis, by End user 7.6. Global Polio Vaccines Market Attractiveness Analysis, by End user 8. Global Polio Vaccines Market Analysis and Forecast, by Vaccines type 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Polio Vaccines Market Value Share Analysis, by Vaccines type 8.4. Global Polio Vaccines Market Size (US$Mn) Forecast, by Vaccines type 8.5. Global Polio Vaccines Market Analysis, by Vaccines type 8.6. Global Polio Vaccines Market Attractiveness Analysis, by Vaccines type 9. Global Polio Vaccines Market Analysis, by Region 9.1. Global Polio Vaccines Market Value Share Analysis, by Region 9.2. Global Polio Vaccines Market Size (US$Mn) Forecast, by Region 9.3. Global Polio Vaccines Market Attractiveness Analysis, by Region 10. North America Polio Vaccines Market Analysis 10.1. Key Findings 10.2. North America Polio Vaccines Market Overview 10.3. North America Polio Vaccines Market Value Share Analysis, by End user 10.4. North America Polio Vaccines Market Forecast, by End user 10.4.1. Hospital 10.4.2. Clinics 10.4.3. Public Services 10.4.4. Others 10.5. North America Polio Vaccines Market Value Share Analysis, by Vaccines type 10.6. North America Polio Vaccines Market Forecast, by Vaccines type 10.6.1. Inactivated Polio Vaccine (IPV) 10.6.2. Oral Polio Vaccine (OPV) 10.7. North America Polio Vaccines Market Value Share Analysis, by Country 10.8. North America Polio Vaccines Market Forecast, by Country 10.8.1. U.S. 10.8.2. Canada 10.9. North America Polio Vaccines Market Analysis, by Country 10.10. U.S. Polio Vaccines Market Forecast, by End user 10.10.1. Hospital 10.10.2. Clinics 10.10.3. Public Services 10.10.4. Others 10.11. U.S. Polio Vaccines Market Forecast, by Vaccines type 10.11.1. Inactivated Polio Vaccine (IPV) 10.11.2. Oral Polio Vaccine (OPV) 10.12. Canada Polio Vaccines Market Forecast, by End user 10.12.1. Hospital 10.12.2. Clinics 10.12.3. Public Services 10.12.4. Others 10.13. Canada Polio Vaccines Market Forecast, by Vaccines type 10.13.1. Inactivated Polio Vaccine (IPV) 10.13.2. Oral Polio Vaccine (OPV) 10.14. North America Polio Vaccines Market Attractiveness Analysis 10.14.1. By End user 10.14.2. By Vaccines type 10.15. PEST Analysis 10.16. Key Trends 10.17. Key Developments 11. Europe Polio Vaccines Market Analysis 11.1. Key Findings 11.2. Europe Polio Vaccines Market Overview 11.3. Europe Polio Vaccines Market Value Share Analysis, by End user 11.4. Europe Polio Vaccines Market Forecast, by End user 11.4.1. Hospital 11.4.2. Clinics 11.4.3. Public Services 11.4.4. Others 11.5. Europe Polio Vaccines Market Value Share Analysis, by Vaccines type 11.6. Europe Polio Vaccines Market Forecast, by Vaccines type 11.6.1. Inactivated Polio Vaccine (IPV) 11.6.2. Oral Polio Vaccine (OPV) 11.7. Europe Polio Vaccines Market Value Share Analysis, by Country 11.8. Europe Polio Vaccines Market Forecast, by Country 11.8.1. Germany 11.8.2. U.K. 11.8.3. France 11.8.4. Italy 11.8.5. Spain 11.8.6. Rest of Europe 11.9. Europe Polio Vaccines Market Analysis, by Country 11.10. Germany Polio Vaccines Market Forecast, by End user 11.10.1. Hospital 11.10.2. Clinics 11.10.3. Public Services 11.10.4. Others 11.11. Germany Polio Vaccines Market Forecast, by Vaccines type 11.11.1. Inactivated Polio Vaccine (IPV) 11.11.2. Oral Polio Vaccine (OPV) 11.12. U.K. Polio Vaccines Market Forecast, by End user 11.12.1. Hospital 11.12.2. Clinics 11.12.3. Public Services 11.12.4. Others 11.13. U.K. Polio Vaccines Market Forecast, by Vaccines type 11.13.1. Inactivated Polio Vaccine (IPV) 11.13.2. Oral Polio Vaccine (OPV) 11.14. France Polio Vaccines Market Forecast, by End user 11.14.1. Hospital 11.14.2. Clinics 11.14.3. Public Services 11.14.4. Others 11.15. France Polio Vaccines Market Forecast, by Vaccines type 11.15.1. Inactivated Polio Vaccine (IPV) 11.15.2. Oral Polio Vaccine (OPV) 11.16. Italy Polio Vaccines Market Forecast, by End user 11.16.1. Hospital 11.16.2. Clinics 11.16.3. Public Services 11.16.4. Others 11.17. Italy Polio Vaccines Market Forecast, by Vaccines type 11.17.1. Inactivated Polio Vaccine (IPV) 11.17.2. Oral Polio Vaccine (OPV) 11.18. Spain Polio Vaccines Market Forecast, by End user 11.18.1. Hospital 11.18.2. Clinics 11.18.3. Public Services 11.18.4. Others 11.19. Spain Polio Vaccines Market Forecast, by Vaccines type 11.19.1. Inactivated Polio Vaccine (IPV) 11.19.2. Oral Polio Vaccine (OPV) 11.20. Rest of Europe Polio Vaccines Market Forecast, by End user 11.20.1. Hospital 11.20.2. Clinics 11.20.3. Public Services 11.20.4. Others 11.21. Rest Of Europe Polio Vaccines Market Forecast, by Vaccines type 11.21.1. Inactivated Polio Vaccine (IPV) 11.21.2. Oral Polio Vaccine (OPV) 11.22. Europe Polio Vaccines Market Attractiveness Analysis 11.22.1. By End user 11.22.2. By Vaccines type 11.23. PEST Analysis 11.24. Key Trends 11.25. Key Developments 12. Asia Pacific Polio Vaccines Market Analysis 12.1. Key Findings 12.2. Asia Pacific Polio Vaccines Market Overview 12.3. Asia Pacific Polio Vaccines Market Value Share Analysis, by End user 12.4. Asia Pacific Polio Vaccines Market Forecast, by End user 12.4.1. Hospital 12.4.2. Clinics 12.4.3. Public Services 12.4.4. Others 12.5. Asia Pacific Polio Vaccines Market Value Share Analysis, by Vaccines type 12.6. Asia Pacific Polio Vaccines Market Forecast, by Vaccines type 12.6.1. Inactivated Polio Vaccine (IPV) 12.6.2. Oral Polio Vaccine (OPV) 12.7. Asia Pacific Polio Vaccines Market Value Share Analysis, by Country 12.8. Asia Pacific Polio Vaccines Market Forecast, by Country 12.8.1. China 12.8.2. India 12.8.3. Japan 12.8.4. ASEAN 12.8.5. Rest of Asia Pacific 12.9. Asia Pacific Polio Vaccines Market Analysis, by Country 12.10. China Polio Vaccines Market Forecast, by End user 12.10.1. Hospital 12.10.2. Clinics 12.10.3. Public Services 12.10.4. Others 12.11. China Polio Vaccines Market Forecast, by Vaccines type 12.11.1. Inactivated Polio Vaccine (IPV) 12.11.2. Oral Polio Vaccine (OPV) 12.12. India Polio Vaccines Market Forecast, by End user 12.12.1. Hospital 12.12.2. Clinics 12.12.3. Public Services 12.12.4. Others 12.13. India Polio Vaccines Market Forecast, by Vaccines type 12.13.1. Inactivated Polio Vaccine (IPV) 12.13.2. Oral Polio Vaccine (OPV) 12.14. Japan Polio Vaccines Market Forecast, by End user 12.14.1. Hospital 12.14.2. Clinics 12.14.3. Public Services 12.14.4. Others 12.15. Japan Polio Vaccines Market Forecast, by Vaccines type 12.15.1. Inactivated Polio Vaccine (IPV) 12.15.2. Oral Polio Vaccine (OPV) 12.16. ASEAN Polio Vaccines Market Forecast, by End user 12.16.1. Hospital 12.16.2. Clinics 12.16.3. Public Services 12.16.4. Others 12.17. ASEAN Polio Vaccines Market Forecast, by Vaccines type 12.17.1. Inactivated Polio Vaccine (IPV) 12.17.2. Oral Polio Vaccine (OPV) 12.18. Rest of Asia Pacific Polio Vaccines Market Forecast, by End user 12.18.1. Hospital 12.18.2. Clinics 12.18.3. Public Services 12.18.4. Others 12.19. Rest of Asia Pacific Polio Vaccines Market Forecast, by Vaccines type 12.19.1. Inactivated Polio Vaccine (IPV) 12.19.2. Oral Polio Vaccine (OPV) 12.20. Asia Pacific Polio Vaccines Market Attractiveness Analysis 12.20.1. By End user 12.20.2. By Vaccines type 12.21. PEST Analysis 12.22. Key Trends 12.23. Key Developments 13. Middle East & Africa Polio Vaccines Market Analysis 13.1. Key Findings 13.2. Middle East & Africa Polio Vaccines Market Overview 13.3. Middle East & Africa Polio Vaccines Market Value Share Analysis, by End user 13.4. Middle East & Africa Polio Vaccines Market Forecast, by End user 13.4.1. Hospital 13.4.2. Clinics 13.4.3. Public Services 13.4.4. Others 13.5. Middle East & Africa Polio Vaccines Market Value Share Analysis, by Vaccines type 13.6. Middle East & Africa Polio Vaccines Market Forecast, by Vaccines type 13.6.1. Inactivated Polio Vaccine (IPV) 13.6.2. Oral Polio Vaccine (OPV) 13.7. Middle East & Africa Polio Vaccines Market Value Share Analysis, by Country 13.8. Middle East & Africa Polio Vaccines Market Forecast, by Country 13.8.1. GCC 13.8.2. South Africa 13.8.3. Rest of Middle East & Africa 13.9. Middle East & Africa Polio Vaccines Market Analysis, by Country 13.10. GCC Polio Vaccines Market Forecast, by End user 13.10.1. Hospital 13.10.2. Clinics 13.10.3. Public Services 13.10.4. Others 13.11. GCC Polio Vaccines Market Forecast, by Vaccines type 13.11.1. Inactivated Polio Vaccine (IPV) 13.11.2. Oral Polio Vaccine (OPV) 13.12. South Africa Polio Vaccines Market Forecast, by End user 13.12.1. Hospital 13.12.2. Clinics 13.12.3. Public Services 13.12.4. Others 13.13. South Africa Polio Vaccines Market Forecast, by Vaccines type 13.13.1. Inactivated Polio Vaccine (IPV) 13.13.2. Oral Polio Vaccine (OPV) 13.14. Rest of Middle East & Africa Polio Vaccines Market Forecast, by End user 13.14.1. Hospital 13.14.2. Clinics 13.14.3. Public Services 13.14.4. Others 13.15. Rest of Middle East & Africa Polio Vaccines Market Forecast, by Vaccines type 13.15.1. Inactivated Polio Vaccine (IPV) 13.15.2. Oral Polio Vaccine (OPV) 13.16. Middle East & Africa Polio Vaccines Market Attractiveness Analysis 13.16.1. By End user 13.16.2. By Vaccines type 13.17. PEST Analysis 13.18. Key Trends 13.19. Key Developments 14. South America Polio Vaccines Market Analysis 14.1. Key Findings 14.2. South America Polio Vaccines Market Overview 14.3. South America Polio Vaccines Market Value Share Analysis, by End user 14.4. South America Polio Vaccines Market Forecast, by End user 14.4.1. Hospital 14.4.2. Clinics 14.4.3. Public Services 14.4.4. Others 14.5. South America Polio Vaccines Market Value Share Analysis, by Vaccines type 14.6. South America Polio Vaccines Market Forecast, by Vaccines type 14.6.1. Inactivated Polio Vaccine (IPV) 14.6.2. Oral Polio Vaccine (OPV) 14.7. South America Polio Vaccines Market Value Share Analysis, by Country 14.8. South America Polio Vaccines Market Forecast, by Country 14.8.1. Brazil 14.8.2. Mexico 14.8.3. Rest of South America 14.9. South America Polio Vaccines Market Analysis, by Country 14.10. Brazil Polio Vaccines Market Forecast, by End user 14.10.1. Hospital 14.10.2. Clinics 14.10.3. Public Services 14.10.4. Others 14.11. Brazil Polio Vaccines Market Forecast, by Vaccines type 14.11.1. Inactivated Polio Vaccine (IPV) 14.11.2. Oral Polio Vaccine (OPV) 14.12. Mexico Polio Vaccines Market Forecast, by End user 14.12.1. Hospital 14.12.2. Clinics 14.12.3. Public Services 14.12.4. Others 14.13. Mexico Polio Vaccines Market Forecast, by Vaccines type 14.13.1. Inactivated Polio Vaccine (IPV) 14.13.2. Oral Polio Vaccine (OPV) 14.14. Rest of South America Polio Vaccines Market Forecast, by End user 14.14.1. Hospital 14.14.2. Clinics 14.14.3. Public Services 14.14.4. Others 14.15. Rest of South America Polio Vaccines Market Forecast, by Vaccines type 14.15.1. Inactivated Polio Vaccine (IPV) 14.15.2. Oral Polio Vaccine (OPV) 14.16. South America Polio Vaccines Market Attractiveness Analysis 14.16.1. By End user 14.16.2. By Vaccines type 14.17. PEST Analysis 14.18. Key Trends 14.19. Key Developments 15. Company Profiles 15.1. Market Share Analysis, by Company 15.2. Competition Matrix 15.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 15.2.2. New Product Launches and Product Enhancements 15.2.3. Market Consolidation 15.2.3.1. M&A by Regions, Investment and Applications 15.2.3.2. M&A Key Players, Forward Integration and Backward Integration 15.3. Company Profiles: Key Players 15.3.1. Sanofi 15.3.1.1. Company Overview 15.3.1.2. Financial Overview 15.3.1.3. Portfolio 15.3.1.4. Business Strategy 15.3.1.5. Recent Developments 15.3.1.6. Development Footprint 15.3.2. GSK 15.3.3. Bibcol 15.3.4. Serum Institute 15.3.5. Tiantan Biological 15.3.6. IMBCA 15.3.7. Panacea Biotec Ltd 15.3.8. Bio-Med 15.3.9. Halfkin Bio-Pharmaceuticals 16. Primary Key Insights

About This Report

Report ID25422
Published DateJAN 2020
Contact Us
Call Now